These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 15389897)
1. Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS. Zheng C; Nennesmo I; Fadeel B; Henter JI Ann Neurol; 2004 Oct; 56(4):564-7. PubMed ID: 15389897 [TBL] [Abstract][Full Text] [Related]
2. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Azzouz M; Ralph GS; Storkebaum E; Walmsley LE; Mitrophanous KA; Kingsman SM; Carmeliet P; Mazarakis ND Nature; 2004 May; 429(6990):413-7. PubMed ID: 15164063 [TBL] [Abstract][Full Text] [Related]
3. Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model. Wang R; Zhang D Eur J Neurosci; 2005 Nov; 22(9):2376-80. PubMed ID: 16262676 [TBL] [Abstract][Full Text] [Related]
4. Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice. Kieran D; Kalmar B; Dick JR; Riddoch-Contreras J; Burnstock G; Greensmith L Nat Med; 2004 Apr; 10(4):402-5. PubMed ID: 15034571 [TBL] [Abstract][Full Text] [Related]
5. Colivelin prolongs survival of an ALS model mouse. Chiba T; Yamada M; Sasabe J; Terashita K; Aiso S; Matsuoka M; Nishimoto I Biochem Biophys Res Commun; 2006 May; 343(3):793-8. PubMed ID: 16564029 [TBL] [Abstract][Full Text] [Related]
6. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261 [TBL] [Abstract][Full Text] [Related]
7. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism. Cervetto C; Frattaroli D; Maura G; Marcoli M Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice. Wang Y; Mao XO; Xie L; Banwait S; Marti HH; Greenberg DA; Jin K J Neurosci; 2007 Jan; 27(2):304-7. PubMed ID: 17215390 [TBL] [Abstract][Full Text] [Related]
9. The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies. Gurney ME J Neurol Sci; 1997 Oct; 152 Suppl 1():S67-73. PubMed ID: 9419057 [TBL] [Abstract][Full Text] [Related]
10. A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. Pompl PN; Ho L; Bianchi M; McManus T; Qin W; Pasinetti GM FASEB J; 2003 Apr; 17(6):725-7. PubMed ID: 12586733 [TBL] [Abstract][Full Text] [Related]
11. The lack of effect of specific overexpression of IGF-1 in the central nervous system or skeletal muscle on pathophysiology in the G93A SOD-1 mouse model of ALS. Messi ML; Clark HM; Prevette DM; Oppenheim RW; Delbono O Exp Neurol; 2007 Sep; 207(1):52-63. PubMed ID: 17597610 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS. Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077 [TBL] [Abstract][Full Text] [Related]
13. [Amyotrophic lateral sclerosis: recent insights from transgenic animal models with SOD1 mutations]. Aoki M Rinsho Shinkeigaku; 2004 Nov; 44(11):788-91. PubMed ID: 15651292 [TBL] [Abstract][Full Text] [Related]
14. Effect of neurophilin ligands on motor units in mice with SOD1 ALS mutations. Shefner JM; Brown RH; Cole D; Chaturvedi P; Schoenfeld D; Pastuszak K; Matthews R; Upton-Rice M; Cudkowicz ME Neurology; 2001 Nov; 57(10):1857-61. PubMed ID: 11723276 [TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Klivenyi P; Ferrante RJ; Matthews RT; Bogdanov MB; Klein AM; Andreassen OA; Mueller G; Wermer M; Kaddurah-Daouk R; Beal MF Nat Med; 1999 Mar; 5(3):347-50. PubMed ID: 10086395 [TBL] [Abstract][Full Text] [Related]
17. Hyperexcitability of cultured spinal motoneurons from presymptomatic ALS mice. Kuo JJ; Schonewille M; Siddique T; Schults AN; Fu R; Bär PR; Anelli R; Heckman CJ; Kroese AB J Neurophysiol; 2004 Jan; 91(1):571-5. PubMed ID: 14523070 [TBL] [Abstract][Full Text] [Related]
18. DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis. Feng X; Peng Y; Liu M; Cui L Neuropharmacology; 2012 Feb; 62(2):1004-10. PubMed ID: 22056419 [TBL] [Abstract][Full Text] [Related]
19. Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model. Tateno M; Sadakata H; Tanaka M; Itohara S; Shin RM; Miura M; Masuda M; Aosaki T; Urushitani M; Misawa H; Takahashi R Hum Mol Genet; 2004 Oct; 13(19):2183-96. PubMed ID: 15294873 [TBL] [Abstract][Full Text] [Related]
20. Altered sensorimotor development in a transgenic mouse model of amyotrophic lateral sclerosis. Amendola J; Verrier B; Roubertoux P; Durand J Eur J Neurosci; 2004 Nov; 20(10):2822-6. PubMed ID: 15548226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]